Company intelligence / Profile preview

Benova

Ownership: Private
Development stage: Commercial

Overview

The US company's clinical results focus on rapid relief of mouth sores with independently tested safety and efficacy via NAMSA studies—showing reduction of pain/inflammation within minutes after use. The pharma arm has multiple programs at NDA/BLA stage targeting infectious diseases and chronic conditions.

Therapeutic areas: GastroenterologyImmunology
Modalities: Oral care solutions with natural ingredients and enzymes (e.g., bromelain, licorice root) for mouth soresSmall molecule drugsNutritional supplements, vitamins, minerals
Industry: Biotech

Beyond the preview

Go deeper on Benova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Benova.

Explore the full profile